Literature DB >> 12851390

Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins.

Nobuo Maita1, Kenji Nishio, Etsuko Nishimoto, Taei Matsui, Yasuo Shikamoto, Takashi Morita, J Evan Sadler, Hiroshi Mizuno.   

Abstract

Bitiscetin, a platelet adhesion inducer isolated from venom of the snake Bitis arietans, activates the binding of the von Willebrand factor (VWF) A1 domain to glycoprotein Ib (GPIb) in vitro. This activation requires the formation of a bitiscetin-VWF A1 complex, suggesting an allosteric mechanism of action. Here, we report the crystal structure of bitiscetin-VWF A1 domain complex solved at 2.85 A. In the complex structure, helix alpha5 of VWF A1 domain lies on a concave depression on bitiscetin, and binding sites are located at both ends of the depression. The binding sites correspond well with those proposed previously based on alanine-scanning mutagenesis (Matsui, T., Hamako, J., Matsushita, T., Nakayama, T., Fujimura, Y., and Titani, K. (2002) Biochemistry 41, 7939-7946). Against our expectations, the structure of the VWF A1 domain bound to bitiscetin does not differ significantly from the structure of the free A1 domain. These results are similar to the case of botrocetin, another snake-derived inducer of platelet aggregation, although the binding modes of botrocetin and bitiscetin are different. The modeled structure of the ternary bitiscetin-VWF A1-GPIb complex suggests that an electropositive surface of bitiscetin may interact with a favorably positioned anionic region of GPIb. These results suggest that snake venom proteins induce VWF A1-GPIbalpha binding by interacting with both proteins, and not by causing conformational changes in VWF A1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851390     DOI: 10.1074/jbc.M305566200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura.

Authors:  Liang Zheng; Yingying Mao; Mohammad S Abdelgawwad; Nicole K Kocher; Mandy Li; Xiangrong Dai; Benjamin Li; X Long Zheng
Journal:  Blood Adv       Date:  2016-11-29

2.  Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib.

Authors:  Mark A Blenner; Xianchi Dong; Timothy A Springer
Journal:  J Biol Chem       Date:  2014-01-03       Impact factor: 5.157

3.  Delimiting the autoinhibitory module of von Willebrand factor.

Authors:  W Deng; K M Voos; J K Colucci; E R Legan; E A Ortlund; P Lollar; R Li
Journal:  J Thromb Haemost       Date:  2018-08-16       Impact factor: 5.824

4.  A mechanism for localized dynamics-driven affinity regulation of the binding of von Willebrand factor to platelet glycoprotein Ibα.

Authors:  Guangjian Liu; Ying Fang; Jianhua Wu
Journal:  J Biol Chem       Date:  2013-07-31       Impact factor: 5.157

5.  Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction.

Authors:  Katleen Broos; Mieke Trekels; Rani Alphonsa Jose; Jonas Demeulemeester; Aline Vandenbulcke; Nele Vandeputte; Tom Venken; Brecht Egle; Wim M De Borggraeve; Hans Deckmyn; Marc De Maeyer
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

6.  Identification of inhibitors of α2β1 integrin, members of C-lectin type proteins, in Echis sochureki venom.

Authors:  Piotr Jakubowski; Juan J Calvete; Johannes A Eble; Philip Lazarovici; Cezary Marcinkiewicz
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-13       Impact factor: 4.219

7.  Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.

Authors:  Marc Baud'huin; Laurence Duplomb; Stéphane Téletchéa; Céline Charrier; Mike Maillasson; Marc Fouassier; Dominique Heymann
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

8.  Mutational Constraints on Local Unfolding Inhibit the Rheological Adaptation of von Willebrand Factor.

Authors:  Alexander Tischer; James C Campbell; Venkata R Machha; Laurie Moon-Tasson; Linda M Benson; Banumathi Sankaran; Choel Kim; Matthew Auton
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

9.  A structural explanation for the antithrombotic activity of ARC1172, a DNA aptamer that binds von Willebrand factor domain A1.

Authors:  Ren-Huai Huang; Daved H Fremont; John L Diener; Robert G Schaub; J Evan Sadler
Journal:  Structure       Date:  2009-11-11       Impact factor: 5.006

10.  Crystal structure of a platelet-agglutinating factor isolated from the venom of Taiwan habu (Trimeresurus mucrosquamatus).

Authors:  Kai-Fa Huang; Tzu-Ping Ko; Chin-Chun Hung; John Chu; Andrew H-J Wang; Shyh-Horng Chiou
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.